1 / 4

Hemophilia Market Size Worth $18.1 Billion By 2027

The global hemophilia market size is anticipated to value USD 18.1 billion until 2027. It is also expected to register a CAGR of 5.5% over the forecasted years, 2020 to 2027.

MarketInsights123
Télécharger la présentation

Hemophilia Market Size Worth $18.1 Billion By 2027

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Hemophilia Market Size Worth $18.1 Billion By 2027 “The global hemophilia market size is anticipated to value USD 18.1 billion until 2027. It is also expected to register a CAGR of 5.5% over the forecasted years, 2020 to 2027. Rising awareness about immediate diagnosis & treatment of diseases and favorable governing policies is projected to propel the market growth.” The global hemophilia market size is anticipated to value USD 18.1 billion until 2027. It is also expected to register a CAGR of 5.5% over the forecasted years, 2020 to 2027. Rising awareness about immediate diagnosis & treatment of diseases and favorable governing policies is projected to propel the market growth. Hemophilia of type A is most commonly seen across the globe and is expected to be four times prevalent than type B. On the other hand, type B hemophilia is projected to witness the fastest growth over the forecasted period, 2020 to 2027 owing to the presence of powerful pipeline products. In 2019, the on-demand treatment segment dominated the global market. The segment of prophylaxis is projected to witness the fastest growth in the upcoming years across the global market on account of its salient features like reduction in the productivity loss that can guarantee good life outcomes. North America accounted for the highest share of around 44.4% across the global market in 2019 due to the rising inclination towards the prophylaxis medical treatment among the millennial population residing in this region. The Asia Pacific is expected to witness the fastest growth in the upcoming years owing to the surge in per capita usage of therapies for catering to factors VIII & IX deficiencies prevailing among citizens of countries like China, Japan, and India. The hemophilia market across the globe includes key players such as Octapharma AG, Pfizer Inc., CSL Behring, Novo Nordisk A/S., Bayer AG, Spark Therapeutics Inc., and Genzyme Corporation. Acquisitions, mergers and regional expansions are generally undertaken by these players for widening their product portfolio and global reach. Request Sample Copy of This Market Research @ https://www.millioninsights.com/industry-reports/global-hemophilia-market/request-sample

  2. Further key findings from the report suggest: • In 2019, the on-demand treatment segment dominated the global market. • The replacement therapy segment accounted for the fastest growth across the global market from 2020 to 2027. • North America accounted for the highest share of around 44.4% across the global market in 2019. • The key players operating in this market are Octapharma AG, Pfizer Inc., CSL Behring, Novo Nordisk A/S., Bayer AG, Spark Therapeutics Inc., and Genzyme Corporation. Browse Full Research Report @ https://www.millioninsights.com/industry-reports/global-hemophilia-market Million Insights has segmented the global hemophilia market on the basis of type, treatment, therapy and region: Hemophilia Type Outlook (Revenue, USD Million, 2016 - 2027) • Hemophilia A • Hemophilia B • Hemophilia C • Others Hemophilia Treatment Outlook (Revenue, USD Million, 2016 - 2027) • On-demand

  3. • Prophylaxis Hemophilia Therapy Outlook (Revenue, USD Million, 2016 - 2027) • Replacement therapy • ITI therapy • Gene therapy Hemophilia Regional Outlook (Revenue, USD Million, 2016 - 2027) • North America • U.S. • Canada • Europe • U.K. • Germany • France • Italy • Spain • Asia Pacific • Japan • China • India • South Korea • Australia • Latin America • Brazil • Mexico • Argentina • Colombia • Middle East & Africa • South Africa • UAE • Saudi Arabia

  4. See More Reports of this Category by Million Insights @ https://www.millioninsights.com/industry/therapeutic-area Get in touch At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions. Contact Person: Ryan Manuel Research Support Specialist, USA Email: ryan@millioninsights.com Global Headquarters Million Insights Felton Office Plaza 6265 Highway 9 Felton, California 95018, United States Phone: 1-408-610-2300 Email: sales@millioninsights.com Asia Pacific Million Insights Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar, Pune, MH, 411016 India Phone: 91-20-65300184

More Related